A Phase Ⅲ Study of Hemay022 in Combination With AI In Advanced Breast Cancer

Conditions: Breast Cancer Interventions: Drug: Hemay022+AI; Drug: Lapatinib+Capecitabine Sponsors: Tianjin Hemay Pharmaceutical Co., Ltd Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials